Kaida BioPharma Launches Social Media Channels
Company dedicated to providing a new hope for patients with treatment-resistant gynecological cancers Lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1 study, targeted for 2025 FORT LAUDERDALE, FL, Sept. 18, 2024 ( …